Michael Catelani
CIK 1689394 · President, COO & CFO · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$155.3K
Companies
2
Total Filings
31
Lifetime Open-Market Net
$86.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIX | President, COO & CFO | 44,500 | $3.49 | $155.3K | $76.0K | 26 | 2026-01-06 |
| Anixa Biosciences Inc (ITUS) Delisted | COO & CFO | 2,250 | — | — | $10.0K | 5 | 2018-09-19 |
Recent Filings · Page 3 of 4
31 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-03 | ANIX | Other (J) | +1,918 | $3.0K | EDGAR |
| 2020-05-04 | ANIX | Other (J) | +1,867 | $3.0K | EDGAR |
| 2019-12-16 | ANIX | Grant (A) | — | $0 | EDGAR |
| 2019-11-04 | ANIX | Other (J) | +912 | $3.0K | EDGAR |
| 2019-09-20 | ANIX | Mixed | — | $0 | EDGAR |
| 2019-05-02 | ANIX | Other (J) | +800 | $2.7K | EDGAR |
| 2018-09-19 | Anixa Biosciences Inc (ITUS) Delisted | Buy (P) | +2,250 | $10.0K | EDGAR |
| 2018-05-14 | Anixa Biosciences Inc (ITUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-08 | Anixa Biosciences Inc (ITUS) Delisted | Mixed | — | $0 | EDGAR |
| 2017-07-25 | Anixa Biosciences Inc (ITUS) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.